Cell Culture Dish Podcast-logo

Cell Culture Dish Podcast


The Cell Culture Dish Podcast – Providing the latest for the cell culture industry!

The Cell Culture Dish Podcast – Providing the latest for the cell culture industry!


United States




The Cell Culture Dish Podcast – Providing the latest for the cell culture industry!






New Lab Set Up – Best Practices for a Successful Start

Dr. Ann Rossi Bilodeau and Dr. Catherine Siler with Corning Life Sciences shared insightful tips for setting up a new lab. We discussed how to create a lab plan, maximize lab space, stay within budget and timelines. They also shared their experience in implementing lab safety and training as part of the new lab launch.


Demystifying the FBS Selection Process – A guide for evaluating product quality, origination and cost consideration

Chris Scanlon talks about how to effectively evaluate which FBS product is right for each application. This includes weighing product quality levels and country of origin. Chris also shares strategies for maximizing purchasing options and new FBS products on the horizon.


Reducing Fill Risk in Drug Product Manufacture Utilizing New State-of-the-Art Systems and Platforms

DQ Wang, PhD, and Vice President, Formulation, Fill and Finish of WuXi Biologics talks about their DP4 multi-product fill & finish facility featuring the Vanrx SA25 robotic, gloveless, isolator-based filling system.


The Challenge of Staying Current with Regulatory Changes – How one company is providing a solution

Ken Chen, MBA, Senior Director, Regulatory Affairs, WuXi Biologics talks about staying current with regulatory changes and how WuXi Biologics recently began publishing a quarterly summary of regulatory updates on new or revised guidance documents from the various global regulatory agencies.


Solving the challenges of standardizing cell counting to ensure reproducibility in experiments, assays and manufacturing processes

Cell counting is a challenging technique, with many pitfalls, that can delay entire projects. We talk with Christian Berg about how new technologies are solving these challenges and enabling standardization of cell counting across organizations.


A Look Towards the Future of 3D Cell Culture – A panel discussion

3D cell culture techniques have become popular because the cell morphology, interactions and tissue-specific architecture more closely resembles that of in vivo tissues.


Computer Aided Biology Platform Helps Companies Meet the Challenges of 21st Century Biomanufacturing

Markus Gershater talks about computer-aided biology and how it addresses several common biomanufacturing challenges. We also discussed ways to build a common culture between science and software.


Balancing Risk, Cost and Speed During Clinical Development While Still Maintaining Quality

We discussed with Thierry Cournez, effective ways for emerging biotechs to collect material quickly and cost-effectively for pre-clinical and clinical studies.


Bi-Specific Antibodies – The development, manufacture and promise of these cutting-edge therapeutics

In this podcast, we conducted a panel discussion with experts from Selexis and KBI Biopharma on bi-specific antibodies. We examined bi-specific antibody development and manufacturing, including current challenges and key solutions. We also discussed the promise of these cutting-edge therapeutics and their future in medicine.


Multistem – A Stable, Off-the Shelf Regenerative Medicine Has Demonstrated Promise in Treating Patients with Acute Respiratory Distress Syndrome or ARDS

In this podcast, we talked with Dr. Gil Van Bokkelen, Chairman and CEO, Athersys about recent clinical breakthroughs in regenerative medicine and manufacturing challenges. We also discussed Multistem and how it has been demonstrated to help patients with ARDS (Acute Respiratory Distress Syndrome).


Rapid At-line Media Analyzer Speeds Process Development by Eliminating Analytics Bottleneck

Dr. Glenn Harris talks about the benefits and challenges of implementing rapid media analysis in process development, including the bottleneck created by outsourcing samples to core labs. We also discussed an easy to implement, benchtop media analyzer that permits comprehensive media analysis in real-time, thus speeding process development efforts.


Non-Animal Origin cell culture supplements and manufacturing aids for biologics manufacturing

Dr. Tobias Hertzig and Dr. Ulrich Tillmann talk about non-animal origin cell culture media supplements. The regulatory advantages of non-animal origin, performance vs. animal origin material and the manufacturing process.


Mesenchymal Stem Cell Culture – Challenges and solutions for isolation, expansion and maintenance

Dr. Jennifer Chain, Scientific Director of Research and Development, Oklahoma Blood Institute, talks about the isolation of mesenchymal stem cells form cadaveric bone marrow and the differences between live and cadaveric donors


CryoVault Freeze and Thaw Platform Provides a Scalable, Robust and Single-Use End-to-End Solution for Bulk Drug Substance

In this podcast, I talked with Max Blomberg, Executive Director of Operations and Andrew Govea, Senior Product Engineer, Meissner about the challenges of handling bulk drug substance, specifically freeze and thaw and how the need for scalability, flexibility and a robust approach led to the development of CryoVault. CryoVault offers a unique and intelligently designed … Continue reading CryoVault Freeze and Thaw Platform Provides a Scalable, Robust and Single-Use End-to-End Solution for Bulk...


Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency

Jonathan Royce, Director, Instruments Business Unit, Vironova talks about analytics in gene therapy manufacturing. Specifically, Jonathan details new technologies to monitor critical quality attributes, reduce development time and increase the number of projects that can be run.


Generating actionable data and analysis in complex models using live-cell analysis

Paul Jantzen, Product Manager for IncuCyte at Sartorius talks about the benefits of real-time live-cell analysis and image processing workflows. We also discussed how live-cell analysis is enabling the use of neuronal cell models to study cell health, morphology, function and cell dynamics.


New Advancements in Cell and Gene Therapy Implementing Precision Medicine

Dr. Paul Wotton, Chief Executive Officer, Obsidian Therapeutics talks about the evolution of cancer therapy and new advancements in the space including precision medicine. Our discussion included Obsidian's cytoDRiVE™ platform that provides a technology, in which the level and timing of protein activity are fully controlled in a dose-dependent manner by an FDA-approved small molecule.


Using 3D cell-based human liver microtissue models in predicting adverse effects caused by chronic exposure to engineered nanomaterial

Shareen Doak and Dr. Wolfgang Moritz talk about the use of 3D cell-based human liver microtissue models to predict the adverse effects of chronic exposure to nanomaterial . We also discussed the use of liver microtissue models for drug discovery and development.


Live Cell Analysis for Neuroscience Research

Susana Alcantara, Senior R&D Scientist and Neuroscience Program Leader, BioAnalytics, Sartorius talks about the ways real-time live-cell analysis is enabling neuroscience research.


Raw Material Quality – Identifying and Mitigating Variation

Cory Card, Principal Scientist Life Sciences, GE Healthcare about raw material quality, its impact on cell culture and technologies to identify and mitigate raw material variation.